![Dana Hilt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dana Hilt
Technik-/Wissenschafts-/F&E-Leiter bei
ACTINOGEN MEDICAL LIMITED
Profil
Dana Charles Hilt is currently Chief Medical Officer at Actinogen Medical Ltd. since 2023.
Former positions include Director-Clinical Neurosciences at Amgen, Inc., Vice President-Clinical Research at Guilford Pharmaceuticals, Inc., Chief Medical Officer at Critical Therapeutics, Inc. from 2006 to 2007, Chief Medical Officer & SVP-Drug Development at FORUM Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Research at Ascend Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Research at ASCEND Therapeutics US LLC, Chief Medical Officer at Lysosomal Therapeutics, Inc. from 2016 to 2019, Chief Medical Officer at Frequency Therapeutics, Inc., and Chief Medical Officer at Brenig Therapeutics, Inc. Education includes undergraduate studies at the University of Maine and a doctorate from Tufts University School of Medicine.
Aktive Positionen von Dana Hilt
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 |
Ehemalige bekannte Positionen von Dana Hilt
| Unternehmen | Position | Ende |
|---|---|---|
Brenig Therapeutics, Inc.
 Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Technik-/Wissenschafts-/F&E-Leiter | 10.06.2025 |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Technik-/Wissenschafts-/F&E-Leiter | 25.09.2007 |
ASCEND Therapeutics US LLC
 ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Technik-/Wissenschafts-/F&E-Leiter | - |
| KORRO BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dana Hilt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinogen Medical Ltd.
 Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Ascend Pharmaceuticals, Inc. | |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
